Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
61M
-
Number of holders
-
112
-
Total 13F shares, excl. options
-
51.5M
-
Shares change
-
-6.35M
-
Total reported value, excl. options
-
$59.7M
-
Value change
-
-$8.57M
-
Put/Call ratio
-
0.81
-
Number of buys
-
52
-
Number of sells
-
-88
-
Price
-
$1.16
Significant Holders of PLIANT THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (PLRX) as of Q2 2025
166 filings reported holding PLRX - PLIANT THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share as of Q2 2025.
PLIANT THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (PLRX) has 112 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 51.5M shares
of 61M outstanding shares and own 84.45% of the company stock.
Largest 10 shareholders include TANG CAPITAL MANAGEMENT LLC (6M shares), Deep Track Capital, LP (3.95M shares), MORGAN STANLEY (3.75M shares), VANGUARD GROUP INC (3M shares), Blue Owl Capital Holdings LP (2.97M shares), UBS Group AG (2.65M shares), CITADEL ADVISORS LLC (2.36M shares), Woodline Partners LP (2.35M shares), Madison Avenue Partners, LP (2.23M shares), and TRV GP IV, LLC (2.13M shares).
This table shows the top 112 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.